From Elad Katz’s experience

Growing assay revenue while doubling GxP functional-testing capacity

At Sartorius Stedim BioOutsource, Elad built and led technical services teams, growing commercial assay revenue while doubling in-house GxP/ICH-compliant functional testing capacity.

Industry
Health and life sciences
Organization
Sartorius Stedim BioOutsource
Elad’s role
Built and led technical services teams

The business need

Sartorius Stedim BioOutsource earns revenue from commercial assays, and its in-house functional testing has to comply with GxP and ICH requirements. The technical services teams Elad built had to grow the first while expanding the second.

What Elad did

  1. Built technical services teams at Sartorius Stedim BioOutsource.
  2. Led those teams while growing commercial assay revenue.
  3. Doubled in-house GxP/ICH-compliant functional testing capacity.

Outcome

  • In-house GxP/ICH-compliant functional testing capacity doubled.
  • Commercial assay revenue grew.

Decisions this experience speaks to

  • We're building a drug discovery or disease-modelling platform and aren't sure it's compatible with how pharma and biotech customers actually run their screening workflows - how do we find out?
  • We have promising preclinical data, but we don't know if it's strong enough, or the right kind of evidence, to support a partnership or licensing conversation?

Related services and use cases

Sources

  1. Elad Katz’s profile on CTO Grand Rounds